Citadel Advisors »

Candel Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $462k 75k 6.20
2023-12-31 $25k 17k 1.47
2023-09-30 $30k 32k 0.93
2023-03-31 $65k 47k 1.37

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Bridgeway Capital Management
Citadel Advisors
Mml Investors Services
Susquehanna International
HB Wealth Management
Bank of New York Mellon
Bank of America Corporation
Charles Schwab Investment Management
Cubist Systematic Strategies

View all funds holding Candel Therapeutics